Chronic Disease Management Solutions Market

Report Description
Table of Contents

Report Description

The worldwide chronic disease management solutions market size is valued to be USD 4,425.4 million in 2021 and is estimated to witness a CAGR of 15.95% during the forecast period. Increase in chronic disease management that help in reducing invasion of chronic diseases is a key driver for the growth of the global chronic disease management solutions market. Additionally, growth in elderly population worldwide and formation of patient-centered commands are some of the other drivers propelling the market growth. However, shortage of qualified professional for the upkeep of information and high investments required for providing subsidiary the infrastructure is expected to restrain the global market growth

Global Chronic Disease Management Solutions Market Size (USD Million), 2021-2029

Source: Erevna Healthcare

By Disease Type

Based on disease type, the market is segmented into cancer, arthritis, diabetes, cardiovascular disease, and others. In 2021, the cancer accounted for the substantial revenue share with a lucrative CAGR during the forecast period. This is attributed to rising incidence of various cancer conditions, increase in acceptance of developed therapies along with the growth in geriatric population worldwide. Cardiovascular disease segment is expected to grow at a profitable CAGR during the forecast period. This is attributed to the increase in global cases of cardiovascular disease resulting from the growing old population, increase in physical inactivity, and increase in number of people with smoking habits.

By Delivery Mode

Based on delivery mode, the market is segmented into on-premises and cloud-based. In 2021, the on-premises segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is attributed to the increase in medical tourism in developing countries and easy access to information regarding patients worldwide. Cloud-based segment is expected to grow at a profitable CAGR during the forecast period. This is attributed to the increasing health care IT sector globally and rise in R&D investments by numerous players in the health care structure.

By Service

Based on service, the market is categorized into consulting service, educational implementation service, implementation service, and other. In 2021, the implementation service segment accounted for a substantial revenue share and is expected to grow with a lucrative CAGR during the forecast period. This is due to the development of various local service providers along with their focus on providing competent and cost-effective services to patients worldwide. The consulting service segment is anticipated to grow at a profitable CAGR during the forecast period, due to the growth in consulting service provides huge potential for chronic disease management.

Regional Insights

In 2021, North America holds the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of major players in the region, increase in the share of healthcare expenditure in the per capita income, rise in demand of patients for economical disease management, increase in occurrence of chronic diseases such as asthma and heart diseases in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the less stringent regulations, growing government and corporate investment in healthcare sector, increasing travel tourism in the developing economies, and rise in favourable initiatives taken by government.

Competitor Insights

Some of the key players in the chronic disease management solutions market are TriZetto Corporation (U.S.); Infosys Limited (India); Pegasystems Inc. (U.S.); Siemens Healthineers AG (Germany); MINES & Associates Inc. (U.S.); Allscripts Healthcare Solutions, Inc. (U.S.); HealthSmart Holdings, Inc. (U.S.); Philips (Netherlands); EXL Healthcare (U.S.); and International Business Machines Corporation (IBM) (U.S.). The leading players operating in the chronic disease management solutions industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The chronic disease management solutions market report is categorized into the following segments and subsegments: